Services
Comprehensive advisory solutions tailored for life science growth.
How we help
Three services across the transaction lifecycle — finding the opportunity, executing the deal, and entering new markets.
Opportunity discovery
Deal intelligence
We find what the market hasn’t priced yet.
Target identification and market mapping for buyers pursuing life sciences manufacturing and services assets — screening the full universe against your specification, not a curated shortlist.
Services
Market mapping and landscape intelligence
Opportunity identification and prioritization
Strategic market positioning
Target identification and engagement
Valuation and market benchmarking
Typical outcomes
Proprietary access to targets before a process begins
Underserved segments and strategic whitespace, mapped
A defensible investment thesis, built on primary evidence
Transaction execution
Curated M&A advisory
Principals on your deal, from first look to close.
Principal-led transaction execution on both sides of the table — buy-side, sell-side, carve-outs and divestitures — with the people who pitch the mandate running it.
Services
Buy-side advisory
Sell-side advisory
Transaction strategy
Deal preparation and sale readiness
Strategic buyer and investor outreach
Carve-out and divestiture analysis
Typical outcomes
Competitive tension built deliberately, not hoped for
Shorter time from mandate to signed
Valuation supported by positioning, not just process
Strategic growth
Insight-driven market entry
Enter new markets on evidence, not assumption.
Assessment of new segments, service lines, and geographies — sized, mapped at operator level, and delivered as a ranked recommendation on whether and how to enter.
Services
Market opportunity assessment
Competitive landscape analysis
Entry strategy development
Partner and acquisition target identification
Strategic expansion roadmaps
Typical outcomes
A costed, sequenced entry strategy
Faster expansion decisions with less internal debate
Market risk identified before capital is committed
How engagements start
Most engagements begin the same way, regardless of which service they end up as.
STEP 1
A conversation. Tell us what you’re looking at — an asset, a market, a live process, or a decision you’re not sure how to frame. No charge, no obligation, and we will tell you if we are not the right firm for it.
STEP 2
A scoped proposal. If there is work to do, we set out what we would do, what you would receive, how long it would take, and what it would cost. One page, not twenty.
STEP 3
A principal on the work. Engagements are led by Kiirsten or Alain from first conversation to close, supported by analysts and specialists selected for the mandate.
We work across pharma and biotech, advanced therapies, CDMOs and pharma services, compounding pharmacies, consumer health, digital health, and MedTech.